Akrikhin
Russia | Health Care- Identification Code:
- OP/02/0329
- Total Operation Cost:
- — USD
- Maturity:
- 84 months
- Operation Status:
-
BSTDB Approved Amount – Approval Date10.000.000 USD – 15 Nov 2002
-
BSTDB Signed Amount – Signed Date-6.742.883 USD – 03 Dec 200410.000.000 USD – 03 Jun 2003
-
Status:Completed
- Description and Purpose of the Operation:
- Financing of a corporate development program including investments in new fixed assets, new products, expansion of the distribution system, as well as financing of working capital needs.
- Countries of Operation:
- Russia (100,00%)
- Financial Product:
- Loans
- Sector:
- Health Care
- Domain:
- Private
- Borrower/Client:
- Akrikhin JSC is the 4th largest producer of pharmaceuticals in Russia with 6% of the domestic market, producing 170 brand names of medicines. Involved in international cooperation programs with leading foreign producers.
- Co-Financers/Participants:
- Short-term credit lines from Russian commercial banks - Sberbank and Alfa Bank
- Guarantors/Sponsors:
- —
- Developmental and Regional Cooperation Impact:
- The BSTDB financing supports the modernization of Russian pharmaceuticals industry in line with international standards, contributes to import substitution and promotes exports of technologically advanced manufacturing products. Promotes trade in the Black Sea region by increasing exports to Armenia, Azerbaijan, Georgia, Moldova, Ukraine.
- Environmental Classification and Impact:
- Screened B1. Corporate environmental audit showed that production facilities are in compliance with environmental regulations and standards with all necessary environmental permits and licenses obtained.
- Operation Leader:
- General Industries, Transport, Tourism 1
- E-mail:
- gitt1@bstdb.org
As of 28 Feb 2026
